Testing and Experimentation Facility for Health
The Testing and Experimentation Facility for Health (TEF-Health) is a significant European initiative designed to accelerate the integration and validation of cutting-edge AI and robotics technologies within the healthcare sector. By providing a multidisciplinary framework for real-life testing and validation, this program aims to enhance the efficiency, safety, and quality of health and care services across Europe, fostering innovation and competitiveness in the European healthcare industry. The program supports the development of trusted and secure AI-enabled solutions, addressing the critical need for robust testing demonstrated during recent health crises.
Who is Funded for TEF-Health
The Testing and Experimentation Facility for Health (TEF-Health) is designed to fund a diverse range of applicants across the European Union, focusing on collaborative efforts to advance AI and robotics in healthcare. Its primary goal is to improve healthcare outcomes, enhance patient and professional experiences, and strengthen Europe's position as a leader in digital health innovation.
What is Funded by TEF-Health
The TEF-Health program supports the development and validation of advanced AI and robotics solutions specifically for the health sector. It encompasses a wide array of applications, from diagnostics and treatment to patient care and hospital logistics, focusing on real-life testing and market readiness.
Type and Scope of TEF-Health Funding
The Testing and Experimentation Facility for Health (TEF-Health) provides grant funding specifically allocated per topic, aiming to support the establishment and operation of a robust testing infrastructure within the European healthcare domain.
Conditions and Requirements for TEF-Health
Applicants for the TEF-Health program must adhere to specific conditions related to application, consortium formation, and other operational requirements to ensure the successful establishment and functioning of the testing facility.
TEF-Health Application Procedure
The application process for the Testing and Experimentation Facility for Health (TEF-Health) call has concluded. Proposals were submitted through a single-stage procedure, underwent evaluation, and applicants have been informed of the results, with grant agreements expected to be signed following formal selection.
Legal Basis of TEF-Health
The Testing and Experimentation Facility for Health (TEF-Health) operates under a robust legal framework established by key European Union regulations, ensuring its legitimacy and guiding its implementation.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
30,000,000 EUR (allocated to this topic)
Allocated Budget:
30,000,000 EUR
Award Channel:
Framework Programme Call
Region:
European Union
Sectors:
Healthcare, Medical Technology, Research and Development, Information and Communication Technology
Beneficiaries:
Healthcare industry, medical and clinical professionals, patients, researchers, industrial developers, innovators, end-users
Application Type:
Consortium Required
Funding Stages:
Experimental Development, Pilot Testing, Product Development, Market Introduction, Commercialization, Scaling, Evaluation
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Additional Partners:
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (Spain), SYNYO GmbH (Austria), EDEN TECH (France), FACULDADE DE MEDICINA DENTÁRIA DA UNIVERSIDADE DE LISBOA (Portugal), Cancer Center Sp. z o.o. (Poland), GC GENOMICS GMBH (Austria), Cephalgo (France), GRANT GARANT SRO (Czechia), GC GENOMICS ESPAÑA, SL (Spain), Grupo Colabora Formación y Proyectos, SL (Spain), ORGANIZACIÓN DE PROFESIONALES, AUTÓNOMOS Y EMPRENDEDORES DE EXTREMADURA (Spain), Poslovno svetovanje Urska Vracun s.p. (Slovenia), FEDERACIÓN EXTREMEÑA DE ASOCIACIONES DE MUJERES RURALES (Spain), BUKOVINIAN STATE MEDICAL UNIVERSITY (Ukraine), BEIA CONSULT INTERNATIONAL SRL (Romania), Flow Analysis and Simulation Team (Greece), GLSMED LEARNING HEALTH SA (Portugal), Innoplexus (Germany), Christos KONTOGIORGIS (Greece)
Website: